Humana (NYSE:HUM – Get Free Report) had its target price boosted by research analysts at Morgan Stanley from $288.00 to $301.00 in a research note issued to investors on Tuesday,Benzinga reports. The ...

Cigna and Humana show strong revenue growth, despite recent financial setbacks. Click here to find out why I reaffirm both ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Key Takeaways U.S. equities were lower in early afternoon trading, with the Dow Jones Industrial Average losing streak ...

Humana Inc said on Tuesday that Chief Financial Officer Susan Diamond was stepping down and Celeste Mellet would replace her, ...

The firm sees Humana (HUM) as most at risk. According to Health Affairs, in 2020, Centers for Medicare and Medicaid Services paid more than $1.32B to Medicare Advantage plans for Veterans Affairs ...

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Learn ...

Morgan Stanley raised the firm’s price target on Humana (HUM) to $301 from $288 and keeps an Equal Weight rating on the shares. Diversified ...

If no new contract is reached for 2025, Trinity’s providers would fall out of network and thus could come with increased costs for people with Medicare Advantage or commercial insurance plans.

First Physicians Group, a multi-specialty medical group affiliated with Sarasota Memorial Health Care System, will no longer ...

The University of Louisville announced Wednesday a continued partnership with the Humana Foundation through a $6.75 million ...

Humana Inc. closed $203.07 short of its 52-week high ($488.89), which the company achieved on December 13th.